TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
MNKD

MannKind Corp

Healthcare · Biotechnology

3.30$ -4.3% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

MannKind Corp (MNKD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 732 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MNKD
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
320 475 481 444 464 394 410 412 495 792 744 732
226 373 383 326 328 268 274 279 359 292 251 246
83 238 193 97 62 46 47 57 127 75 53 53
141 295 301 248 252 197 182 179 260 171 134 111
22 15 20 23 18 12 29 27 19 38 29 43
27 29 26 25 27 28 29 28 27 35 49 44
1.9 1.9 1.9 1.9 1.9 1.9 1.9 1.9 1.9 68 68 68
1.1 1.1 1.1 1.0 5.3 5.3 5.2 5.2 5.1 5.1 320 316
572 721 711 670 674 473 469 467 539 843 804 800
96 104 100 80 72 82 116 112 109 171 135 143
20 20 20 13 – 13 36 36 49 49 13 2.1
17 9.6 7.1 9.6 6.4 6.8 5.0 10 7.3 9.0 16 11
253 249 244 228 228 36 – – 73 318 319 319
-252 -246 -230 -226 -210 -79 -59 -55 -45 -51 -59 -67
-3,231 -3,229 -3,219 -3,221 -3,209 -3,202 -3,189 -3,188 -3,180 -3,196 -3,213 -3,232
269 324 325 273 285 291 321 311 312 314 308 309

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?